ECOLAB INC.
ECLAPI behind this page
ECL Q3 2025 request
Playground key active
/api/financials?ticker=ECL&year=2025&quarter=3
Pick an endpoint and run the request.
Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 4,165 | 3,998.5 | +4.2% |
Show Product Lines breakouts |
|||
| Product and equipment sales | 3,262.6 | 3,156 | +3.4% |
| Product and equipment sales · Global Institutional and Specialty | 1,296.4 | 1,274.1 | +1.8% |
| Product and equipment sales · Global Life Sciences | 174.7 | 159.9 | +9.3% |
| Product and equipment sales · Global Water | 1,791.5 | 1,722 | +4.0% |
| Service and lease sales | 902.4 | 842.5 | +7.1% |
| Service and lease sales · Global Institutional and Specialty | 297.5 | 282.6 | +5.3% |
| Service and lease sales · Global Life Sciences | 10 | 8.3 | +20.5% |
| Service and lease sales · Global Pest Elimination | 331.8 | 307.2 | +8.0% |
| Service and lease sales · Global Water | 263.1 | 244.4 | +7.7% |
Show Business Segments breakouts |
|||
| Global Institutional and Specialty | 1,593.9 | 1,556.7 | +2.4% |
| Global Institutional and Specialty · Asia Pacific | 83.7 | 79.3 | +5.5% |
| Global Institutional and Specialty · CA | 69 | 69.8 | -1.1% |
| Global Institutional and Specialty · CN | 50.8 | 46.4 | +9.5% |
| Global Institutional and Specialty · Europe | 271.5 | 267 | +1.7% |
| Global Institutional and Specialty · India, Middle East and Africa | 25.7 | 28.5 | -9.8% |
| Global Institutional and Specialty · Latin America | 50.4 | 52.6 | -4.2% |
| Global Institutional and Specialty · Operating Segments | 1,544.8 | 1,525.7 | +1.3% |
| Global Institutional and Specialty · US | 1,042.8 | 1,013.1 | +2.9% |
| Global Life Sciences | 184.7 | 168.2 | +9.8% |
| Global Life Sciences · Asia Pacific | 12.5 | 9.5 | +31.6% |
| Global Life Sciences · CA | 1.3 | 0.8 | +62.5% |
| Global Life Sciences · CN | 12.4 | 14.5 | -14.5% |
| Global Life Sciences · Europe | 95.1 | 84.1 | +13.1% |
| Global Life Sciences · India, Middle East and Africa | 6.8 | 6.5 | +4.6% |
| Global Life Sciences · Latin America | 4.3 | 5.5 | -21.8% |
| Global Life Sciences · Operating Segments | 171 | 161.7 | +5.8% |
| Global Life Sciences · US | 52.3 | 47.3 | +10.6% |
| Global Pest Elimination | 331.8 | 307.2 | +8.0% |
| Global Pest Elimination · Asia Pacific | 8.9 | 8 | +11.3% |
| Global Pest Elimination · CA | 3.6 | 3.1 | +16.1% |
| Global Pest Elimination · CN | 15.7 | 15.3 | +2.6% |
| Global Pest Elimination · Europe | 54.4 | 47 | +15.7% |
| Global Pest Elimination · India, Middle East and Africa | 1.8 | 1.8 | 0.0% |
| Global Pest Elimination · Latin America | 15.6 | 14.8 | +5.4% |
| Global Pest Elimination · Operating Segments | 322.6 | 301.7 | +6.9% |
| Global Pest Elimination · US | 231.8 | 217.2 | +6.7% |
| Global Water | 2,054.6 | 1,966.4 | +4.5% |
| Global Water · Asia Pacific | 236.7 | 234.4 | +1.0% |
| Global Water · CA | 58.7 | 56.1 | +4.6% |
| Global Water · CN | 105.4 | 100.5 | +4.9% |
| Global Water · Europe | 435 | 416.1 | +4.5% |
| Global Water · India, Middle East and Africa | 124.4 | 121.8 | +2.1% |
| Global Water · Latin America | 210.1 | 201.9 | +4.1% |
| Global Water · Operating Segments | 1,953.5 | 1,897.6 | +2.9% |
| Global Water · US | 884.3 | 835.6 | +5.8% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 173.1 | 111.8 | +54.8% |
| Operating Segments | 3,991.9 | 3,886.7 | +2.7% |
| Cost of Revenue | 2,299.4 | 2,261.5 | +1.7% |
Show Product Lines breakouts |
|||
| Product and equipment sales | 1,789.1 | 1,771.2 | +1.0% |
| Service and lease sales | 510.3 | 490.3 | +4.1% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 0.2 | 0.9 | -77.8% |
| Global Institutional and Specialty · Operating Segments | 765.8 | 798.4 | -4.1% |
| Global Life Sciences · Operating Segments | 93.6 | 92.5 | +1.2% |
| Global Pest Elimination · Operating Segments | 179 | 168 | +6.5% |
| Global Water · Operating Segments | 1,163.6 | 1,137.3 | +2.3% |
Show Equity Components breakouts |
|||
| Aoci Derivative Qualifying As Hedge Excluded Component Parent · Reclassification Out Of Accumulated Other Comprehensive Income | 0.3 | 2.5 | -88.0% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2,202.2 | 2,197.1 | +0.2% |
| Selling, General & Administrative | 1,079.2 | 1,024.8 | +5.3% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 49.2 | 49.3 | -0.2% |
| Global Institutional and Specialty · Operating Segments | 414 | 399.7 | +3.6% |
| Global Life Sciences · Operating Segments | 49.3 | 45.3 | +8.8% |
| Global Pest Elimination · Operating Segments | 76.2 | 73.2 | +4.1% |
| Global Water · Operating Segments | 453.9 | 435.5 | +4.2% |
Show Equity Components breakouts |
|||
| Aoci Derivative Qualifying As Hedge Excluded Component Parent · Reclassification Out Of Accumulated Other Comprehensive Income | -0.3 | 1.7 | -117.6% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 1,042.6 | 1,003 | +3.9% |
| Other Nonrecurring Income Expense | 26.2 | -332.6 | +107.9% |
Show Product Lines breakouts |
|||
| Product and equipment, and service and lease · Cost Of Sales | 0.3 | 0.9 | -66.7% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 24.3 | -332.6 | +107.3% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 24.3 | -332.6 | +107.3% |
Show Income Statement Location breakouts |
|||
| Cost Of Sales | 0.3 | 0.9 | -66.7% |
| Special (gains) and charges | 26.2 | -332.6 | +107.9% |
| Operating Income | 760.2 | 1,044.8 | -27.2% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | -73.7 | 282.4 | -126.1% |
| Global Institutional and Specialty · Operating Segments | 365 | 327.6 | +11.4% |
| Global Life Sciences · Operating Segments | 28.1 | 23.9 | +17.6% |
| Global Pest Elimination · Operating Segments | 67.4 | 60.5 | +11.4% |
| Global Water · Operating Segments | 336 | 324.8 | +3.4% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 37.4 | 25.6 | +46.1% |
| Operating Segments | 722.8 | 1,019.2 | -29.1% |
| Non-Operating Income (Expense) | -12.8 | -12.9 | +0.8% |
| Interest Expense Net | 55.3 | 70.4 | -21.4% |
Show Equity Components breakouts |
|||
| Aoci Derivative Qualifying As Hedge Excluded Component Parent · Reclassification Out Of Accumulated Other Comprehensive Income | -0.4 | -0.5 | +20.0% |
| Income Before Taxes | 717.7 | 987.3 | -27.3% |
| Income Tax Expense (Benefit) | 128 | 246.5 | -48.1% |
| Net Income | 589.7 | 740.8 | -20.4% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 4.7 | 4.3 | +9.3% |
| Parent | 585 | 736.5 | -20.6% |
| Retained Earnings | 585 | 736.5 | -20.6% |
| Net Income Loss Attributable To Noncontrolling Interest | 4.7 | 4.3 | +9.3% |
| Net Income | 585 | 736.5 | -20.6% |
| EPS (Basic) | 2.06 | 2.6 | -20.8% |
| EPS (Diluted) | 2.05 | 2.58 | -20.5% |
| Wtd Avg Shares (Basic) | 283.5 | 283.6 | -0.0% |
| Wtd Avg Shares (Diluted) | 285.4 | 286 | -0.2% |
| Interest Income | -19.3 | -16 | -20.6% |
| Comprehensive Income | 684.4 | 782.1 | -12.5% |
| Interest Expense | 74.6 | 86.4 | -13.7% |
| Operating Lease Lease Income | 141.9 | 133.5 | +6.3% |
| Professional Fees (Q) | — | — | — |
Show Income Statement Location breakouts |
|||
| Special (gains) and charges · One Ecolab Initiative Program | 8.2 | 7 | +17.1% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 1,955.8 | 1,261.1 | +55.1% |
| Accounts Receivable | 3,114.1 | 2,883 | +8.0% |
| Inventory | 1,534.9 | 1,572.4 | -2.4% |
| Other Assets Current | 501.9 | 401.8 | +24.9% |
| Total Current Assets | 7,106.7 | 6,118.3 | +16.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 4,062.6 | 3,545.5 | +14.6% |
| Goodwill | 8,113 | 7,898.7 | +2.7% |
Show Business Segments breakouts |
|||
| Global Institutional and Specialty | 1,043.2 | 611.6 | +70.6% |
| Global Life Sciences | 2,498.5 | 2,869.9 | -12.9% |
| Global Pest Elimination | 172.2 | 170.3 | +1.1% |
| Global Water | 4,399.1 | — | — |
| Operating Lease Right-of-Use Assets | 767.7 | 688.2 | +11.6% |
| Other Non-Current Assets | 712.1 | 568.8 | +25.2% |
| Total Assets | 23,897.6 | 22,101.6 | +8.1% |
| Intangible Assets | 1,905.5 | 2,052.1 | -7.1% |
| Deferred Tax Assets | 166.9 | 120.7 | +38.3% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 3,135.5 | 3,282.1 | -4.5% |
| Current Liabilities | |||
| Debt Current | 16.2 | 643 | -97.5% |
| Accounts Payable | 1,868.4 | — | — |
| Employee Related Liabilities Current | 606 | 604.9 | +0.2% |
| Accrued Income Taxes Current | 188 | 235.1 | -20.0% |
| Other Liabilities Current | 1,509.6 | — | — |
| Total Current Liabilities | 4,188.2 | 4,709.1 | -11.1% |
| Non-Current Liabilities | |||
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 597.8 | 625 | -4.4% |
| Deferred Tax Liabilities | 176.9 | 264.6 | -33.1% |
| Other Non-Current Liabilities | 527.3 | 401.5 | +31.3% |
| Total Liabilities | 14,143.7 | 13,526.1 | +4.6% |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 8,052.7 | 6,974.5 | +15.5% |
| Operating Lease Liability Noncurrent Excluded From Long Term Debt | 600.8 | 551.4 | +9.0% |
| Stockholders' Equity | |||
| Common Stock | 369.1 | 367.6 | +0.4% |
| Additional Paid In Capital Common Stock | 7,448.5 | 7,108.2 | +4.8% |
| Retained Earnings | 12,475.9 | 11,228.4 | +11.1% |
| Accumulated Other Comprehensive Income | -1,903.9 | -1,853.8 | -2.7% |
| Treasury Stock Value | -8,670.6 | -8,302.6 | -4.4% |
| Total Stockholders' Equity | 9,719 | 8,547.8 | +13.7% |
| Minority Interest | 34.9 | 27.7 | +26.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 9,753.9 | 8,575.5 | +13.7% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -1,903.9 | -1,853.8 | -2.7% |
| Additional Paid In Capital | 7,448.5 | 7,108.2 | +4.8% |
| Common Stock | 369.1 | 367.6 | +0.4% |
| Noncontrolling Interest | 34.9 | 27.7 | +26.0% |
| Parent | 9,719 | 8,547.8 | +13.7% |
| Retained Earnings | 12,475.9 | 11,228.4 | +11.1% |
| Treasury Stock Common | -8,670.6 | -8,302.6 | -4.4% |
| Total Liabilities & Equity | 23,897.6 | 22,101.6 | +8.1% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation | 493.8 | 473.7 | +4.2% |
| Adjustment For Amortization | 226.5 | 226.2 | +0.1% |
| Deferred Income Taxes And Tax Credits | -57.1 | -149.7 | +61.9% |
| Stock-Based Compensation | 109.5 | 109.5 | 0.0% |
| Pension And Other Postretirement Benefit Contributions | -67.1 | -43.7 | -53.5% |
| Pension And Other Postretirement Benefit Expense | 10.4 | 11.5 | -9.6% |
| Restructuring Costs | -12.5 | -11.7 | -6.8% |
| Gain Loss On Sale Of Business | 1.1 | -382.7 | +100.3% |
| Other Non-Cash Items | 20.4 | 17.7 | +15.3% |
| Change in Accounts Receivable | -150.3 | -109.3 | -37.5% |
| Change in Inventory | -37.6 | -163.6 | +77.0% |
| Increase Decrease In Other Operating Assets | 34.1 | -41.1 | +183.0% |
| Change in Accounts Payable | -47.8 | 277.7 | -117.2% |
| Increase Decrease In Other Operating Liabilities | -185.6 | 180.3 | -202.9% |
| Net Cash from Operations | 1,862.5 | 2,047.2 | -9.0% |
| Investing Activities | |||
| Capital Expenditures | -716.2 | -634.8 | -12.8% |
| Proceeds From Sale Of Productive Assets | 46.4 | 3.3 | +1306.1% |
| Payments To Acquire Businesses And Interest In Affiliates | -0.5 | -56.4 | +99.1% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | -14.9 | 889.7 | -101.7% |
| Other Investing Activities | -43.8 | -8.1 | -440.7% |
| Net Cash from Investing | -729 | 193.7 | -476.4% |
| Financing Activities | |||
| Proceeds From Repayments Of Short Term Debt | 1.1 | 3.3 | -66.7% |
| Proceeds From Issuance Of Long Term Debt | 1,019 | — | — |
| Repayments Of Long Term Debt | -674.2 | -630.4 | -6.9% |
| Share Repurchases | -374.6 | -983.7 | +61.9% |
| Payments Of Dividends Common Stock | -564.4 | -502.9 | -12.2% |
| Proceeds From Stock Options Exercised | 182 | 232.8 | -21.8% |
| Proceeds From Payments For Other Financing Activities | -10.6 | -2.5 | -324.0% |
| Net Cash from Financing | -421.7 | -1,884 | +77.6% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -12.8 | -15.3 | +16.3% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations | 699 | 341.6 | +104.6% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 1,955.8 | 1,261.1 | +55.1% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.